Price Alert

Relmada Therapeutics Inc. (RLMD)

NASDAQ: RLMD · Real-Time Price · USD

0.60

-0.06 (-9.64%)

At close: Aug 19, 2025, 3:57 PM

Relmada Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	1.35M	1.15M	3.86M	1.48M	2.09M	1.34M	4.09M	6.7M	14.47M	28.89M	5.4M	42.52M	37.26M	44.93M	44.44M	11.45M	4.67M	3.8M
Short-Term Investments	19.27M	25.91M	41.05M	52.63M	68.35M	82.28M	92.23M	99.57M	104.06M	103.55M	142.93M	141.63M	174.69M	175.72M	167.47M	76.64M	104.4M	98.9M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22.27K	44.09K	65.45K
Other Long-Term Assets	21.98K	21.98K	21.98K	21.98K	53.62K	43.13K	43.13K	47.72K	34.59K	34.88K	34.88K	16.09K	35.24K	28.29K	28.29K	25K	25K	25K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	512.43K	n/a	42.23K	65.45K	86.38K	84.59K	82.84K	81.13K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.04M	n/a	3.48M	9.98M	11.3M	2.58M	1.47M	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	256.19K	n/a	n/a	n/a	n/a	n/a
Total Current Assets	21.09M	27.66M	45.8M	55.7M	70.97M	84.37M	97.51M	109.1M	122M	135.53M	152.87M	187.11M	215.74M	225.78M	223.3M	90.89M	110.7M	103.78M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	452.00
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	21.98K	21.98K	21.98K	21.98K	53.62K	43.13K	43.13K	47.72K	34.59K	34.88K	34.88K	16.09K	35.24K	28.29K	28.29K	47.27K	69.09K	90.91K
Total Assets	21.12M	27.68M	45.82M	55.72M	71.03M	84.41M	97.55M	109.15M	122.04M	135.57M	152.91M	187.12M	215.77M	225.81M	223.33M	90.93M	110.77M	103.87M
Account Payables	1.36M	1.27M	4.13M	2.35M	4.17M	5.19M	3.51M	2.86M	4.85M	4.42M	5.26M	10.43M	7.54M	10.67M	11.19M	12.71M	10.46M	8.08M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	2.23M	1.02M	1.15M	5.74M	4.35M	n/a	5.68M	n/a	n/a	n/a	n/a	8.52M	0.00	0.00	0.00	0.00	2.4M	3.87M
Total Current Liabilities	5.13M	5.23M	10.29M	8.09M	9.54M	12.36M	12.19M	8.42M	10.7M	10.1M	12.47M	20.78M	18.92M	15.41M	15.06M	18.25M	13.92M	12.72M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	32.12K	7.5K	4.47K	12.56K	n/a	n/a	n/a	-218	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	32.12K	7.5K	4.47K	12.56K	n/a	n/a	n/a	-218	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	5.17M	5.24M	10.3M	8.1M	9.54M	12.36M	12.19M	8.42M	10.7M	10.1M	12.47M	20.78M	18.92M	15.41M	15.06M	18.25M	13.92M	12.72M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	33.19K	33.19K	30.17K	30.17K	30.17K	30.17K	30.1K	30.1K	30.1K	30.1K	30.1K	28.64K	30.02K	29.4K	27.74K	17.5K	17.47K	16.75K
Retained Earnings	-668.31M	-658.44M	-640.88M	-622.22M	-600.5M	-582.73M	-560.9M	-535.74M	-513.74M	-488.43M	-462.11M	-424.17M	-384.75M	-344.81M	-305.07M	-270.69M	-228.08M	-201.53M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	-0.00	-0.00	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	15.95M	22.44M	35.52M	47.63M	61.49M	72.05M	85.36M	100.73M	111.34M	125.47M	140.44M	166.34M	196.85M	210.4M	208.26M	72.69M	96.85M	91.15M
Total Investments	19.27M	25.91M	41.05M	52.63M	68.35M	82.28M	92.23M	99.57M	104.06M	103.55M	142.93M	141.63M	174.69M	175.72M	167.47M	76.64M	104.4M	98.9M